HIFU Danger Zones: Mapping the Face Before You Treat

Depth is fixed. Anatomy is not.

A HIFU cartridge bends sound to a point a set distance from its face. No dial moves that distance, which is why our note on focus depths insists depth is a cartridge, not a setting.

Flip it around and you have the safety problem. The focal point lands where the geometry says, and whatever occupies that plane takes the heat: collagen, fat, a nerve branch, the tissue lying over bone.

Light works differently, as our technology notes explain. A laser aims itself by absorption, the logic Anderson and Parrish set out in Science in 1983: brief pulses of selectively absorbed radiation damage pigmented targets, no precise aiming needed. Focused ultrasound has no chromophore to chase. Anatomy is the only aiming system you get.

The contraindicated areas, and the ones merely to be avoided

You don't have to invent this list. The instructions for use published for the Ulthera system, the platform most of the peer-reviewed literature was built on, sort its restrictions into grades that don't mean the same thing.

Area or condition	Grade in the instructions for use	In your room
Open wounds or lesions in the treatment area	Contraindicated	Reschedule
Severe or cystic acne in the treatment area	Contraindicated	Screen on intake, confirm same day
Active implants such as pacemakers or defibrillators, or metallic implants in the treatment area	Contraindicated	Ask before the deposit
Thyroid gland, thyroid cartilage and trachea	Recommended to be avoided	Neck packages stop at a marked line
Major vessels and nerves	Recommended to be avoided	Mandibular border and anterior neck mapped first
Breast tissue or breast implants	Recommended to be avoided	Decolletage needs its own boundary
Eyes, eyelids, and within the orbital rim	Recommended to be avoided, plus a warning against any technique letting energy reach the eye	Work stays outside the bony rim
Mechanical implants, dermal fillers, breast implants	Not recommended directly over, never evaluated over them	Filler history goes on the intake form
An existing keloid	Treatment energy not recommended directly on it	Route scar requests to a clinician

Read the grades. Contraindications, areas recommended to be avoided and materials never evaluated are three different claims, and the third is missing evidence rather than proven harm.

A further list names groups never evaluated at all: pregnancy and breastfeeding, children, anticoagulant users, and disease states from hemorrhagic disorders and herpes simplex to diabetes, epilepsy and Bell's palsy. Not proven harmful. Never studied. That gap is yours to write a clinic policy for.

Nerves, vessels, and the front of the neck

Facial nerve branches do not sit at one uniform depth. The 4.5mm plane a jawline lift aims for is the same plane the instructions tell you to keep major vessels and nerves clear of, and no cartridge knows what it enters. That overlap is why mapping exists.

What gets reported? The Ulthera instructions list transient local muscle weakness from inflammation of a motor nerve and transient numbness from a sensory nerve, each typically resolving in two to six weeks. Pain, paresthesia and tingling sit in the same window. No permanent facial nerve injuries were reported during the clinical trials.

Post-market data is less tidy. A 2025 systematic review in Dermatologic Surgery covering 19 articles and 506 patients found transient edema, erythema and pain most common. The same authors pulled 106 records from the FDA device experience database, where lipoatrophy, neurologic sequelae including nerve damage, focal numbness, dysesthesia and ptosis, and scarring appeared most frequently. Voluntary reporting, no denominator: it says what can happen, never how often. A 2017 case report in the same journal is titled, plainly, "Transient Nerve Damage After Microfocused Ultrasound With Visualization."

Transient is the word the evidence supports. It's also a client on your phone for six weeks.

The neck raises the stakes. Those packages sell well, and they sit over the one region holding an endocrine gland, an airway and the carotid within a cartridge's reach. A 2022 case report in Frontiers in Cardiovascular Medicine describes a 41-year-old woman who developed headache and signs of cerebral infarction after a focused ultrasound treatment aimed at neck lines, with imaging showing severe stenosis and dissection of the left internal carotid artery, recanalised after surgery. The authors call for better visualisation and more rigorous operator training against off-target risk from inadequate focal depth.

One case is not a rate. It is a reason to draw the neck map in ink.

Bone, thickness, and why one setting is not safe across one face

Here's what surprises new buyers. A cartridge that behaves beautifully on the cheek can be wrong two centimetres away.

The skin anatomy training material in our engineering archive puts the epidermis at roughly 0.1 to 0.4mm and the dermis at roughly 0.5 to 4mm, over a subcutaneous layer of loose connective tissue and fat lobules running down to the fascia. That archive calls it rich in blood vessels, lymphatic vessels and nerves. They sit in the plane your energy crosses.

A 2023 ultrasonographic study in Skin Research and Technology measured 99 participants at eight facial points.

Facial point	Full skin thickness	Dermal thickness
Lateral forehead (thinnest site)	mean 1.31mm, 95% CI 1.20 to 1.42	mean 0.98mm, 95% CI 0.87 to 1.08
Mouth corner (thickest site)	mean 1.64mm, 95% CI 1.54 to 1.75	mean 1.30mm, 95% CI 1.20 to 1.41

Sex moved them too: at the lateral forehead, 1.62mm in males against 1.23mm in females. One Korean cohort, not a universal chart, and still enough to retire the house setting applied face-wide.

Bone is the other half. The Ulthera instructions describe imaging the dermal and subdermal layers to confirm depth such as to avoid bone, illustrated with a case where a more superficial transducer is the better choice. The 2021 Pan-Asian expert consensus in the Journal of Clinical and Aesthetic Dermatology agrees: SMAS depth differs with weight, body mass index, age, sex and target area. Too deep reaches bone. Too superficial can burn.

Check what your platform hands the operator. The published specification for the HF-01 4D HIFU platform lists two handles, cartridge depths from 1.5mm to 16mm, and 4 to 7MHz at 10 to 200W. No tissue imaging module, and neither have most consoles at that price. Without imaging, the map and the operator's training carry that load. Ask before you sign.

Filler, threads and implants

Most clients booking a lift have had something injected. Ask.

The manufacturer position is that treatment is not recommended directly over mechanical implants, dermal fillers or breast implants, never having been evaluated over those materials. The literature is not identical: the Pan-Asian consensus reports energy delivered over hyaluronic acid and calcium hydroxylapatite filler did not change filler appearance, increase inflammation or induce migration. Both can be true. One is an evidence gap in a regulated document, and that document is what a complaint gets judged against.

Threads sit on thinner evidence again. Take the history, note date and material, refer anything unknown.

Sequencing runs the other way too. The post-treatment guidance in our skin fundamentals training manual keeps clients off fillers and injectables for two weeks after an energy session, and off direct or indirect heat for three days, with particular caution for those who pigment readily. Focused ultrasound doesn't target melanin, but any inflammatory insult in a darker phototype carries real risk of post-inflammatory hyperpigmentation, covered in our patient selection guide.

Drawing the map before line one

Treatment mapping is two things: a drawing on the client's face, and a matching record on paper or screen. Both, every time.

1. Mark the avoid areas first. Orbital rim, thyroid and anterior neck, mandibular border, any site with known filler or implant. Shade them, don't just note them.
2. Then zones and vectors. Which cartridge goes where, and which way the lift pulls.
3. Fix the line budget per region first. Deciding counts mid-session is how a face ends up asymmetric.
4. Deliver with disciplined spacing. The Ulthera instructions put 2 to 3mm between lines, warn that inadequate spacing could overheat tissue, and attribute burns to tilting, wrong spacing and gel pockets. Technique faults, not machine faults.
5. Record what went where. Cartridge depth, lines per region, total lines, energy, date, operator.

Why so pedantic? When a client reports numbness on the left jaw three days later, the only useful question is what you delivered there, and memory is a poor witness. Our operator training guide covers the handover. Hands-on technique belongs with a qualified trainer, never a written guide.

The call-back, and what to put in writing

Set the escalation path before you need it. A client reporting numbness, tingling, asymmetry or one-sided weakness gets three things: no further treatment there, a dated note with photographs, and referral to a qualified clinician. Diagnosis was never the operator's job. Give a named contact and follow-up date, and log it either way.

Three things belong in the supplier file before the machine ships.

• A full instructions-for-use document in English, contraindications and avoid areas included. Not a brochure.
• Focal depth and line capacity for every cartridge quoted, plus whether the platform images tissue.
• Named training with a named trainer, and cover for your second therapist.

None of it is exotic. A supplier who hands it over is telling you how the relationship will run, and our equipment buyer guides are largely about reading those signals early.

Evidence and further reading

Educational material for equipment buyers and operators. It is not medical advice, an operating protocol or a promise of clinical outcome.

• Ulthera, Inc. Ulthera System Instructions for Use, 1015107IFU Rev 05. Section 2.2 Contraindications states the system is contraindicated for use in patients with open wounds or lesions in the treatment area; severe or cystic acne in the treatment area; and active implants (e.g., pacemakers or defibrillators), or metallic implants in the treatment area. Section 2.3 Precautions states the system has not been evaluated for use over various materials and that treatment is therefore not recommended directly over mechanical implants, dermal fillers or breast implants; that treatment energy is not recommended for use directly on an existing keloid; that the system has not been evaluated in patients on an anticoagulant treatment plan; that the following areas should be avoided during treatment, namely thyroid gland, thyroid cartilage and trachea, major vessels and nerves, breast tissue or breast implants, and eyes, eyelids and within the orbital rim; and that the system has not been evaluated in pregnant or breast-feeding women, children, or those with a hemorrhagic disorder or hemostatic dysfunction, active systemic or local skin disease that may alter wound healing, herpes simplex, autoimmune disease, diabetes, epilepsy or Bell's palsy. Section 2.4 carries the warning that the system should not be used on a patient's eyes or in a location or technique where ultrasound energy can reach the eye. Section 2.1 lists imaging of dermal and subdermal layers to confirm appropriate depth of treatment such as to avoid bone, and section 7.3.4 illustrates visualization of dermal and subdermal layers and bone showing that a more superficial transducer may be more appropriate. Section 2.5 Potential Side Effects records transient local muscle weakness due to inflammation of a motor nerve and transient numbness due to inflammation of a sensory nerve, each typically resolving in 2 to 6 weeks, with transient pain, paresthesia and tingling in the same window, and states that no permanent injuries to facial nerves were reported during clinical trials; burns which may or may not result in permanent scar formation are attributed to incorrect treatment technique such as tilting the transducer, incorrect line spacing and gel pockets. Section 7.3.5 directs the operator to move the transducer 2-3 mm to adjacent tissue for the next treatment line and warns that delivering lines without adequate spacing could overheat tissue.
• Humphrey VS, Rambhia PH, Gmyrek R, Chapas A. Microfocused Ultrasound With Visualization: A Systematic Review of Adverse Events and Risk of Subsequent Facelift Compromise. Dermatologic Surgery 2025;51(4):424-429. Nineteen articles with data on 506 patients were identified; transient edema, erythema and postprocedural pain were observed most often; instances of significant treatment-related adverse events were limited in the scientific literature apart from one case of subcutaneous atrophy; data from 106 records were extracted from the manufacturer and user facility device experience (MAUDE) database, in which lipoatrophy, neurologic sequelae including nerve damage, focal numbness, dysesthesia and ptosis, and scarring were reported with the most frequency.
• Marr K, Carruthers JDA, Humphrey S. Transient Nerve Damage After Microfocused Ultrasound With Visualization. Dermatologic Surgery 2017;43(6):894-896.
• Du F, Shao J, Lai Z, Li K, Wang C, Liu B. Case report: Traumatic carotid artery dissection after 7D High-Intensity Macro- and Micro-Focused Ultrasound treatment for skin laxity of the neck. Frontiers in Cardiovascular Medicine 2022;9:913754. A 41-year-old woman developed headache and clinical manifestations of cerebral infarction after the treatment, aimed at removing neckline; head and neck magnetic resonance angiography and computed tomography angiogram revealed severe stenosis and dissection of the left internal carotid artery, with recanalization confirmed after surgery; the authors propose that better visualization systems and more rigorous operator training are needed to reduce the risk of off-target damage from inadequate focal depth.
• Jeong KM, Seo JY, Kim A, Kim YC, Baek YS, Oh CH, Jeon J. Ultrasonographic analysis of facial skin thickness in relation to age, site, sex, and body mass index. Skin Research and Technology 2023;29(8):e13426. Ninety-nine participants measured at eight facial points. Section 3.2 as published: the thickest full skin thickness was measured at the mouth corner (mean 1.64 mm, 95% CI 1.54-1.75) and the thinnest full skin thickness at the lateral forehead (mean 1.31 mm, 95% CI 1.20-1.42); the thickest point in the dermis was the mouth corner (mean 1.30, 95% CI 1.20-1.41) and the thinnest was the lateral forehead (mean 0.98, 95% CI 0.87-1.08). Section 3.3 as published: the lateral forehead was on average 1.62 and 1.23 mm for males and females respectively (p < 0.05), with full skin and dermal thickness thinner in females at six of the eight sites.
• Park JY, Lin F, Suwanchinda A, et al. Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel's Gold Standard Consensus. Journal of Clinical and Aesthetic Dermatology 2021;14(5). SMAS and superficial fascia depths differ with patient weight, body mass index, age, sex and target area; ultrasound imaging should be used to estimate SMAS depth and select transducers and line counts per tissue plane; targeting too deep can affect bone while treating too superficially can burn; gel layer thickness affects final treatment depth; delivery of microfocused ultrasound energy over areas injected with hyaluronic acid and calcium hydroxylapatite fillers did not change filler appearance, increase inflammation or induce product migration.
• Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220(4596):524-527. Suitably brief pulses of selectively absorbed optical radiation cause selective damage to pigmented structures, cells and organelles in vivo, and precise aiming is unnecessary because inherent optical and thermal properties provide target selectivity; the absorption-driven aiming that focused ultrasound does not have.